These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9239451)

  • 1. Effects of clonidine in a primed rat model of acute hepatic porphyria.
    Goerz G; Bolsen K; Böhrer H; Fritsch C; Kalka K; Rominger KL
    Arzneimittelforschung; 1997 Jun; 47(6):731-3. PubMed ID: 9239451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of glucose metabolism enzymes in an acute porphyria model. Role of reactive oxygen species.
    Lelli SM; San Martín de Viale LC; Mazzetti MB
    Toxicology; 2005 Dec; 216(1):49-58. PubMed ID: 16125296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of clonidine on the porphyrin metabolism in female rats.
    Goerz G; Bolsen K; Vardarman E; Rominger KL
    Arzneimittelforschung; 1993 Dec; 43(12):1309-12. PubMed ID: 8141818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental latent and acute porphyria in the non-fasted rat; preventive effect of propranolol.
    Schoenfeld N; Mamet R; Mevasser R; Atsmon A
    Scand J Clin Lab Invest; 1991 Dec; 51(8):667-73. PubMed ID: 1806982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria.
    Marsden JT; Rees DC
    J Clin Pathol; 2014 Jan; 67(1):60-5. PubMed ID: 23908454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic alteration of tryptophan metabolism in an acute porphyria model Its relation with gluconeogenic blockage.
    Lelli SM; Mazzetti MB; San Martín de Viale LC
    Biochem Pharmacol; 2008 Feb; 75(3):704-12. PubMed ID: 17996218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How porphyrinogenic drugs modeling acute porphyria impair the hormonal status that regulates glucose metabolism. Their relevance in the onset of this disease.
    Matkovic LB; D'Andrea F; Fornes D; San Martín de Viale LC; Mazzetti MB
    Toxicology; 2011 Nov; 290(1):22-30. PubMed ID: 21889565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
    Bonkovsky HL; Healey JF; Lourie AN; Gerron GG
    Am J Gastroenterol; 1991 Aug; 86(8):1050-6. PubMed ID: 1713408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    Sardh E; Harper P; Andersson DE; Floderus Y
    Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and simultaneous determination of 5-aminolaevulinic acid and porphobilinogen in urine by hydrophilic interaction liquid chromatography-electrospray ionisation/tandem mass spectrometry.
    Benton CM; Couchman L; Marsden JT; Rees DC; Moniz C; Lim CK
    Biomed Chromatogr; 2012 Aug; 26(8):1033-40. PubMed ID: 22740490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyrinogenic effects of atracurium, vecuronium, and pancuronium in a primed rat model.
    Böhrer H; Schmidt H; Bach A; Martin E; Kohl B; Bolsen K; Goerz G
    Lab Anim Sci; 1994 Aug; 44(4):326-30. PubMed ID: 7983842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted Liver.
    Yasuda M; Erwin AL; Liu LU; Balwani M; Chen B; Kadirvel S; Gan L; Fiel MI; Gordon RE; Yu C; Clavero S; Arvelakis A; Naik H; Martin LD; Phillips JD; Anderson KE; Sadagoparamanujam VM; Florman SS; Desnick RJ
    Mol Med; 2015 Jun; 21(1):487-95. PubMed ID: 26062020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephrologists and porphyrias].
    Canavese C; Gabrielli D; Guida C; Cappellini MD
    G Ital Nefrol; 2002; 19(4):393-412. PubMed ID: 12369042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute intermittent porphyria in childhood: a population-based study.
    Hultdin J; Schmauch A; Wikberg A; Dahlquist G; Andersson C
    Acta Paediatr; 2003 May; 92(5):562-8. PubMed ID: 12839285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of beta-adrenergic blocking agents on experimental porphyria induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) in vivo and in vitro.
    Schoenfeld N; Epstein O; Atsmon A
    Biochim Biophys Acta; 1976 Aug; 444(1):286-93. PubMed ID: 8132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational disease model of phenobarbital-induced acute attacks in an acute intermittent porphyria mouse model.
    Vera-Yunca D; Serrano-Mendioroz I; Sampedro A; Jericó D; Trocóniz IF; Fontanellas A; Parra-Guillén ZP
    Mol Genet Metab; 2019 Nov; 128(3):367-375. PubMed ID: 30639045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Glucose effect" and rate limiting function of uroporphyrinogen synthase on porphyrin metabolism in hepatocyte culture: relationship with human acute hepatic porphyrias.
    Doss M; Sixel-Dietrich F; Verspohl F
    J Clin Chem Clin Biochem; 1985 Sep; 23(9):505-13. PubMed ID: 4067519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of haem biosynthesis inhibitors and inducers on intestinal iron absorption and liver haem biosynthetic enzyme activities.
    Laftah AH; Simpson RJ; Peters TJ; Raja KB
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):273-80. PubMed ID: 18384829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications.
    Galbraith RA; Drummond GS; Kappas A
    J Clin Invest; 1985 Dec; 76(6):2436-9. PubMed ID: 4077989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterization of porphobilinogen deaminase-deficient mice during phenobarbital induction of heme synthesis and the effect of enzyme replacement.
    Johansson A; Möller C; Fogh J; Harper P
    Mol Med; 2003; 9(9-12):193-9. PubMed ID: 15208740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.